Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;15(2):2262130.
doi: 10.1080/19490976.2023.2262130. Epub 2023 Oct 2.

Diet and gut microbial associations in irritable bowel syndrome according to disease subtype

Affiliations

Diet and gut microbial associations in irritable bowel syndrome according to disease subtype

Yiqing Wang et al. Gut Microbes. 2023 Dec.

Abstract

The role of diet and the gut microbiome in the etiopathogenesis of irritable bowel syndrome (IBS) is not fully understood. Therefore, we investigated the interplay between dietary risk factors and gut microbiota in IBS subtypes using a food frequency questionnaire and stool metagenome data from 969 participants aged 18-65 years in the ZOE PREDICT 1 study, an intervention study designed to predict postprandial metabolic responses. We identified individuals with IBS subtype according to the Rome III criteria based on predominant bowel habits during symptom onset: diarrhea (i.e. looser), constipation (i.e. harder), and mixed. Participants with IBS-D (n = 59) consumed more healthy plant-based foods (e.g. whole grains, leafy vegetables) and fiber, while those with IBS-C (n = 49) tended to consume more unhealthy plant-based foods (e.g. refined grains, fruit juice) than participants without IBS (n = 797). Microbial diversity was nominally lower in patients with IBS-D than in participants without IBS or with IBS-C. Using multivariable-adjusted linear regression, we identified specific microbiota variations in IBS subtypes, including slight increases in pro-inflammatory taxa in IBS-C (e.g. Escherichia coli) and loss of strict anaerobes in IBS-D (e.g. Faecalibacterium prausnitzii). Our analysis also revealed intriguing evidence of interactions between diet and Faecalibacterium prausnitzii. The positive associations between fiber and iron intake and IBS-diarrhea were stronger among individuals with a higher relative abundance of Faecalibacterium prausnitzii, potentially driven by carbohydrate metabolic pathways, including the superpathway of β-D-glucuronide and D-glucuronate degradation. In conclusion, our findings suggest subtype-specific variations in dietary habits, gut microbial composition and function, and diet-microbiota interactions in IBS, providing insights into potential microbiome-informed dietary interventions.

Keywords: Fiber; diarrhea; functional bowel disorder; glycan metabolism; microbial enzymes.

PubMed Disclaimer

Conflict of interest statement

ZOE PREDICT 1 was supported by Zoe Ltd., for which Dr. Chan and Dr. Drew served as investigators. Dr. Chan served as a consultant for Pfizer Inc. and Boehringer Ingelheim for unrelated studies and a grant support from Pfizer Inc. and Freenome for unrelated studies. Dr. Huttenhower and Dr. Segata are on the Scientific Advisory Board of Zoe Ltd. Dr. Berry and Dr. Spector have equity in Zoe Ltd. Mr. Wolf is an employee of Zoe Ltd. Dr. Staller has received research support from Ironwood and Urovant and has served as a consultant for Anji, Ardelyx, Arena, Gelesis, GI Supply, Restalsis, and Sanofi. No other disclosures have been reported.

Figures

Figure 1.
Figure 1.
Dietary intakes and gut microbial composition differed by IBS subtypes.
Figure 2.
Figure 2.
Random forest model classifying IBS subtypes according to gut microbial taxa, functional pathways, and host factors.
Figure 3.
Figure 3.
Taxonomic-level results were comparable with prior studies.
Figure 4.
Figure 4.
The association between dietary fiber and IBS-D varied by the relative abundance of Faecalibacterium prausnitzii.

References

    1. Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC.. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908–13. doi: 10.1016/S2468-1253(20)30217-X. - DOI - PubMed
    1. Kibune-Nagasako C, García-Montes C, Silva-Lorena SL, Aparecida-Mesquita M. Irritable bowel syndrome subtypes: clinical and psychological features, body mass index and comorbidities. Rev Esp Enferm Dig. 2016;108(2):59–64. doi: 10.17235/reed.2015.3979/2015. - DOI - PubMed
    1. Choghakhori R, Abbasnezhad A, Hasanvand A, Amani R. Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: association with digestive symptoms and quality of life. Cytokine. 2017;93:34–43. doi: 10.1016/j.cyto.2017.05.005. - DOI - PubMed
    1. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. Jama. 2015;313(9):949–958. doi: 10.1001/jama.2015.0954. - DOI - PubMed
    1. Melchior C, Douard V, Coëffier M, Gourcerol G. Fructose and irritable bowel syndrome. Nutr Res Rev. 2020;33(2):235–243. doi: 10.1017/S0954422420000025. - DOI - PubMed

Publication types

LinkOut - more resources